Easton Pharmaceuticals Announces Preparations for North

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Easton Pharmaceuticals Announces Preparations for North American Product(s) Launch

TORONTO, ON--(Marketwired - Sep 15, 2014) - Easton Pharmaceuticals ( OTC : EAPH ) Announces it has finalized and prepares for the launch of 3 initial OTC therapeutic products and other additional products for a marketing and sales launch.

As announced, Easton has previously received all required ingredients and has readied 3 of its main OTC therapeutic products which are VIORRA TM, SKIN RENOU HA, and KENESTRIN GEL. The 3 products will be made immediately available once packaging is delivered which involves containers and labeling. Included with the 3 initial Easton products are an additional 3 cosmetic products as a result of an agreement with a Toronto, Canada based manufacturer who will manufacture and supply the U.S. and Canadian markets. The line of products will be formally announced in the next few short weeks which is expected to be in conjunction with a marketing plan and partner who have been in discussions with the company over the past month for U.S. and Canadian distribution. The new marketing partner will be replacing the previous agreement signed with Global Links ( OTC : GLCO ) following Easton's termination of the agreement originally signed in May of 2014.

The missing packaging and labeling component is only expected to take 2 weeks for completion. Products are expected to be available for sale within the next 30 to 45 days in preparation for the upcoming Christmas buying season on Easton's website as well as multiple distributors as part of a comprehensive marketing strategy. Full details to be made shortly available. The initial products being launched, VIORRA TM, SKIN RENOU HA, and KENESTRIN GEL are expected to command a lucrative minimum gross margin of 40-50% at a wholesale level, which is considered very conservative. Detailed retail pricing will be announced on launch date.

VIORRA ™ = (Will service a broad female market including a growing ageing female population, but can also be utilized by younger woman to assist in naturally treating FSAD and lack of lubricity, a condition affecting millions of women of different ages. )

SKIN RENOU HA = ( A product to service the multi billion dollar anti wrinkle cosmetic industry which utilizes the company's proprietary and patented transdermal delivery matrix to deliver Hyaluronic Acid and other active ingredients to treat wrinkles and ageing. )

KENESTRIN GEL = ( A product to help treat the multi billion dollar Rheumatoid Arthritis industry which affects people of all ages. The products main active ingredient is Hyaluronic Acid which acts as a cushion and lubricant in joints and other tissues which is applied utilizing the company's patented transdermal delivery matrix. )

Easton will continue to utilize BMV Medica for its distribution of the same products in Mexico and Latin American markets and will use products manufactured in Canada for the short term to supply the Mexican and Latin American market until a final agreement is reached with a Mexican manufacturer which Dr. Daniel Bag and BMV has stated is close to finalization.

Carla Pepe, CEO of Easton Pharmaceuticals, commented "Although the launch of Viorra and our other OTC therapeutic products have recently taken a back seat to our medical marijuana initiatives, the company is quickly moving towards the launch of these products to take advantage of the Christmas shopping season and to demonstrate our commitment to this part of our business. We believe our marketing strategy which we expect to disclose very shortly will provide good exposure and resulting sales of all products being launched."

In other developments, Easton reports that its Canadian Medical Marijuana initiative and its exclusive option with its partner regarding a letter to build it has received towards a medical marijuana national growers license is progressing. Two new medical marijuana licenses were recently issued by health Canada as they deal with a backlog and implement new security requirements for licensed producers and company's who have received letters to build. Other news and updates soon expected regarding a possible Canadian dual listing and on its partnership with AMFIL Technologies.

About Easton Pharmaceuticals Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues geared towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 50% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.

For More Information Visit: http://www.eastonpharmaceuticalsinc.com  

Safe Harbor This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.

Contact: Carla Pepe Easton Pharmaceuticals Inc. Tel: +1(416) 619-0291 Tel: +1(347) 284-0192 Email: info@eastonpharmaceuticalsinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 305

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 266

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 415

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 43

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 279

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 85

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 19

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 294

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 164

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Cryptocurrency Through Sustainable Mining Solutions

Updated Category News Views 132

Ripple and Dogecoin Capture Market Attention Recently, Ripple, known by its trading symbol XRP, regained significant visibility in the cryptocurrency market following a major legal victory against a regulatory body. This resurgence has reignited interest among investors and enthusiasts alike. Meanwhile, Dogecoin has been experiencing a renaissance, driven by the ambitious...

Continue Reading
General Dynamics Sees Growth in Q2 Earnings and Revenue

Updated Category News Views 147

General Dynamics Q2 Financial Highlights General Dynamics reported remarkable financial results for the second quarter of 2025, showcasing a revenue of $13 billion, which marks an 8.9% increase compared to the same quarter last year. The company achieved operating earnings of $1.3 billion, translating to a diluted earnings per share (EPS) of $3.74, reflecting a 14.7%...

Continue Reading
FIU Shines as a Top Public University in New Ranking

Updated Category News Views 77

FIU Ranks High in TIME's New College List Alright, listen up. The latest college buzz isn't just noise—Florida International University (FIU) is sitting pretty at No. 23 among public universities in TIME's first crack at America's Best Colleges for the 2026-2027 term. They're also punching in at No. 62 overall out of 500 schools. For a university that's been...

Continue Reading
Recent Net Asset Value Disclosure for Hargreave Hale AIM VCT

Updated Category News Views 174

Understanding the Latest Net Asset Value Announcement The Hargreave Hale AIM VCT PLC has recently made an important announcement regarding its Net Asset Value (NAV). This provides valuable insights for investors and stakeholders looking to evaluate the fund's performance. It is crucial for those following this investment vehicle to stay informed about NAV updates, as...

Continue Reading
Orvana Minerals Corp. Reports Financial Results for Q1 FY2026

Updated Category News Views 191

Orvana Minerals Corp. Financial Performance Overview TSX:ORV Orvana Minerals Corp. (TSX: ORV) has recently disclosed its financial statements for the first quarter of the fiscal year 2026 through its subsidiary, Empresa Minera Paitití, S.A. (EMIPA). These unaudited results are now available for viewing on the Bolivian stock market. The disclosure marks an important...

Continue Reading